Eikon Therapeutics, Inc. Balance Sheet
Eikon Therapeutics, Inc.'s total assets for Q2 2026 were $779.57M, a decrease of -8.37% from the previous quarter. EIKN total liabilities were $313.07M for the fiscal quarter, a 4.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
